Skip to content

Comparing the Effectiveness of Bioactive and SLA Surface Implants in the Back of the Jaw

Comparison Of Clinical And Radiological Outcomes Of Bioactive Surface Implants With Sla Surface Implants In Mandibular Posterior Region A Randomised Controlled Trial - nil

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/083161
Enrollment
22
Registered
2025-03-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 8- Other Procedures

Interventions

Intervention1: Bioactive surface implant: Comparison Of Clinical And Radiological Outcomes Of Bioactive Surface Implants With Sla Surface Implants In Mandibular Posterior Region A Randomised Control

Sponsors

Dr Vidhi Vyas
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Healthy adult patients (age 18-75) requiring dental implants in the mandibular posterior region (premolar or molar areas). 2. Adequate bone volume and density in the posterior mandible for implant placement (based on preoperative radiographic assessment). 3. No history of systemic diseases that could interfere with wound healing or osseointegration (e.g., uncontrolled diabetes, immune disorders). 4. Non-smokers 5. Patients who can provide informed consent and are willing to follow-up for 3 months post-surgery.

Exclusion criteria

Exclusion criteria: 1. Severe periodontitis or untreated oral infections. 2. Insufficient bone volume or poor bone quality that cannot be corrected with bone grafting procedures. 3. Known allergies to titanium or other implant materials. 4. Pregnancy or breastfeeding. 5. Uncontrolled medical conditions (e.g., severe cardiovascular disease, cancer, autoimmune disorders). 6. Participation in other clinical trials involving implants.

Design outcomes

Primary

MeasureTime frame
Implant stability Marginal Bone lossTimepoint: Baseline

Secondary

MeasureTime frame
Implant stability Marginal Bone lossTimepoint: Base line Three months

Countries

India

Contacts

Public ContactDr Mishal Shah

Ahmedabad dental college and hospital

drmishalshah29@gmail.com9909218929

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026